Menu

Blog

Page 2042

Aug 3, 2023

DNA tilts and stretches underlie differences in mutation rates across genomes

Posted by in categories: biotech/medical, chemistry, evolution, genetics, health

Each cell in the body stores its genetic information in DNA in a stable and protected form that is readily accessible for the cell to carry on its activities. Nevertheless, mutations—changes in genetic information—occur throughout the human genome and can have a powerful influence on human health and evolution.

“Our team is interested in a classical question about mutation—why do in the genome vary so tremendously from one DNA location to another? We just do not have a clear understanding of why this occurs,” said Dr. Md. Abul Hassan Samee, assistant professor of integrative physiology at Baylor College of Medicine and corresponding author of the work.

Previous studies have shown that the DNA sequences flanking a mutated position—the sequence context—play a strong role in the mutation rate. “But this explanation still leaves unanswered questions,” Samee said. “For example, one type of mutation occurs frequently in a specific sequence context while a different type of mutation occurs infrequently in that same sequence context. So, we think that a different mechanism could explain how mutation rates vary in the genome. We know that each building block or base that makes up a DNA sequence has its own 3D chemical shape. We proposed, therefore, that there is a connection between DNA shape and rates, and this paper shows that our idea was correct.”

Aug 3, 2023

Multi-omic rejuvenation and life span extension on exposure to youthful circulation

Posted by in categories: biotech/medical, genetics, life extension

Heterochronic parabiosis ameliorates age-related diseases in mice, but how it affects epigenetic aging and long-term health was not known. Here, the authors show that in mice exposure to young circulation leads to reduced epigenetic aging, an effect that persists for several months after removing the youthful circulation.

Aug 3, 2023

Matters Arising: The Information Theory of Aging Has Not Been Tested

Posted by in categories: biotech/medical, genetics, life extension, neuroscience

Yang and co-workers state that “using inducible changes to the epigenome, we find that the act of faithful DNA repair advances aging at physiological, cognitive, and molecular levels, including erosion of the epigenetic landscape, cellular exdifferentiation, senescence, and advancement of the DNA methylation clock, which can be reversed by OSK-mediated rejuvenation. These data are consistent with the information theory of aging, which states that a loss of epigenetic information is a reversible cause of aging.” There is extensive evidence that the key reagent, restriction endonuclease I-PpoI, is cytotoxic. Moreover, the corresponding author published two papers—neither cited—showing that I-PpoI targeted to specific cell types causes a p53 response and cell elimination within a month. Despite globally inducing I-PpoI activation for seven times as long as required to induce a progeric effect, no analysis of mice during this critical window was presented. No significant conclusion of Yang was demonstrated.

Aug 3, 2023

The University of Kansas Health System

Posted by in category: health

Offers relief treatments for all different types ofs, including migraines and clusters.

Aug 3, 2023

‘Eerie-blue glow’ seen with nuclear fusion for the first time

Posted by in category: nuclear energy

SHINE Technologies.

With the world looking for cleaner ways to meet its energy demands, nuclear power is gaining favor once again as a low-carbon source of energy. Companies are also focused on harnessing energy from nuclear fusion instead, which does not raise concerns about nuclear waste.

Aug 3, 2023

Buy Alert: 3 Quantum Computing Stocks Nearing Super Attractive Entry Points

Posted by in categories: economics, quantum physics, robotics/AI

In the fascinating landscape tech realm, quantum computing stock opportunities could prove to be incredibly lucrative over time. The notion of quantum computing, born over two decades ago, is now gaining solid traction on The Street. Moreover, the technology, rooted in the mysteries of quantum mechanics, aims to boost computing speeds significantly.

The advancements in quantum computing are impossible to ignore, with continuous improvements and decreasing development costs. Moreover, the sector’s convergence with cloud computing opens doors for broader accessibility among researchers and software developers.

Furthermore, as the digital economy and artificial intelligence sectors grow, global spending on cloud computing is expected to reach a whopping $1 trillion annually within the next decade. Quantum computing appears to be on the cusp of becoming a game-changer, and it might be the most opportune time to load up on affordable quantum computing stocks.

Aug 3, 2023

Storing dead people at —196°C

Posted by in categories: cryonics, law, life extension

In Switzerland, there’s a new cryonics company: and they invited me to have a look around. I had questions: legal, practical, and ethical, and I want to be clear: this is not an endorsement. I just wasn’t going to turn down that invitation. ■ Tomorrow Bio: https://www.tomorrow.bio/

Camera: Martin Bäbler.

Continue reading “Storing dead people at —196°C” »

Aug 3, 2023

AI used to read breast cancer screenings a safe success

Posted by in categories: biotech/medical, health, robotics/AI

A study has revealed that AI can be used to detect cancer from mammogram screenings and could improve efficiencies and reduce workloads for health workers.

Aug 3, 2023

Award-winning company uses quantum sensors to develop a lightweight, wearable brain scanner

Posted by in categories: neuroscience, quantum physics, wearables

Googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-3759129–1’); });

Earl.

Aug 3, 2023

Tackling an aggressive, treatment-resistant lymphoma

Posted by in category: biotech/medical

Anaplastic large cell lymphoma, a form of non-Hodgkin lymphoma, is the most common aggressive lymphoma in children. Chemotherapy and radiation fail to cure about 30% of cases. When tumors are driven by the oncogene ALK—which is the case for the majority of children—kinase inhibitor drugs like crizotinib are very effective in blocking tumor growth. They also lack the serious side effects of chemotherapy.

However, ALK inhibitors also very expensive—about $80,000 a year—and must be taken for a lifetime. As soon as they’re stopped, the lymphoma comes back. Roberto Chiarle, MD, a hematopathologist and researcher at Boston Children’s Hospital, wanted to know why.

“ALK inhibitors can control the lymphoma, but you cannot reach a cure,” he says. “Why do persist for so long?”